AI Verdict
EXPO has stronger fundamentals based on our AI analysis.
EXPO vs EXOZ Fundamental Comparison
| Metric | EXPO | EXOZ |
|---|---|---|
| Revenue | $582.0M | $70,069.0 |
| Net Income | $106.0M | $-6.5M |
| Net Margin | 18.2% | -9,281.8% |
| ROE | 27.2% | -121.0% |
| ROA | 13.6% | -84.3% |
| Current Ratio | 2.40x | 4.53x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $2.07 | $-0.78 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EXPO vs EXOZ: Frequently Asked Questions
Is EXPO or EXOZ a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), EXPO has stronger fundamentals. EXPO is rated BUY (78% confidence) while EXOZ is rated STRONG SELL (95% confidence). This is not investment advice.
How does EXPO compare to EXOZ fundamentally?
EXPONENT INC has ROE of 27.2% vs EXOZYMES INC.'s -121.0%. Net margins are 18.2% vs -9,281.8% respectively.
Which stock pays higher dividends, EXPO or EXOZ?
EXPO has a dividend yield of N/A or no dividend while EXOZ has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EXPO or EXOZ for long term?
For long-term investing, consider that EXPO has BUY rating with 78% confidence, while EXOZ has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EXPO vs EXOZ?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EXPO vs EXOZ, the AI consensus favors EXPO based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.